Skip to content

Effect of Chocolate Consumption Prior to Prolonged Sitting on Cardiovascular Health in Adults

Effects of Dark, Milk, and White Chocolate Consumption Prior to Prolonged Sitting on Cardiovascular Health in Healthy Adults: A Randomized Crossover Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07556627
Acronym
CHOC-SIT
Enrollment
22
Registered
2026-04-29
Start date
2026-04-04
Completion date
2026-12-01
Last updated
2026-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Health During Prolonged Sitting

Keywords

Dark Chocolate, Milk Chocolate, White Chocolate, Prolonged Sitting, Blood Pressure, Pulse Wave Velocity, Heart Rate Variability

Brief summary

This randomized controlled crossover trial investigates the acute effects of consuming dark, milk, and white chocolate before prolonged sitting on cardiovascular health in healthy adults. Each participant completes three separate study visits and receives all three chocolate conditions in a randomized order, with a 7-day washout period between visits. Blood pressure, heart rate, pulse wave velocity, blood glucose, appetite, pain, and calf circumference are measured before and during a 3-hour sitting perio

Detailed description

Prolonged sitting is associated with acute adverse changes in vascular and metabolic health. Cocoa-rich chocolate contains bioactive compounds that may influence vascular responses; however, the effects of different chocolate types consumed before prolonged sitting are not fully understood. This study is a randomized controlled crossover trial in healthy adults. Each participant completes three experimental visits and receives all three chocolate conditions (dark chocolate, milk chocolate, and white chocolate) in a randomized sequence determined before enrollment. A 7-day washout period is maintained between visits to minimize carryover effects. At each visit, baseline measurements are obtained before chocolate consumption. Participants then consume the assigned chocolate condition, followed by post-consumption assessments and a standardized 3-hour sitting period. Repeated measurements are collected throughout the sitting period. Outcome measures include blood pressure, heart rate, pulse wave velocity, capillary blood glucose, appetite visual analogue scale(VAS), pain visual analogue scale(VAS), and calf circumference. The study aims to compare acute physiological responses among the three chocolate conditions before prolonged sitting.

Interventions

DIETARY_SUPPLEMENTdark chocolate

Participants consume dark chocolate 1 hour before prolonged sitting.

DIETARY_SUPPLEMENTMilk Chocolate

Participants consume milk chocolate 1 hour before prolonged sitting.

DIETARY_SUPPLEMENTWhite Chocolate

Participants consume white chocolate 1 hour before prolonged sitting.

Sponsors

King Saud University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Each participant receives all three chocolate conditions (dark, milk, and white chocolate) in randomized order across three separate visits with a 7-day washout period between visits.

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Adult males and females aged between 18 and 40 years. * Participants with blood pressure within the normal or elevated range (less than 130/80 mmHg), according to the American Heart Association guidelines.

Exclusion criteria

* Females with menopause will be excluded due to the physiological effects of menopause and to ensure hormonal stability. * Participants with nut allergies, due to the possibility that the chocolate used may contain traces of nuts resulting from manufacturing processes. * Participants with dairy allergies, due to the use of milk chocolate and white chocolate, and the possibility that dark chocolate may contain traces of milk resulting from manufacturing processes . * Participants with chronic diseases that may affect the study variables, such as cardiovascular diseases, respiratory diseases, diabetes, or any medical condition that affects circulation. * Participants using medications that may affect the targeted physiological measurements in the study, such as antihypertensive medications, antidiabetic medications, or drugs affecting the autonomic nervous system. * Participants with a body mass index (BMI) ≥ 30 kg/m², due to the association between obesity and vascular dysfunction, characterized by increased blood pressure and arterial stiffness, which may lead to variability in vascular responses. * Participants who are physically active (≥150 minutes per week of moderate-to-vigorous physical activity), to avoid the impact of high levels of training on vascular responses. * Smokers, due to the chronic effects of smoking on endothelial function and arterial stiffness. * Participants with back injuries that limit their ability to sit continuously for three hours. * Female participants who are pregnant, breastfeeding, due to the associated hormonal changes that may influence the physiological indicators measured in the study.

Design outcomes

Primary

MeasureTime frameDescription
Blood Pressure (Systolic, Diastolic, Mean Arterial Pressure)Baseline, 1 hour post-chocolate, and hourly during 3 hours of prolonged sittingBlood pressure will be measured using an automated sphygmomanometer under each chocolate condition (dark, milk, white).
Pulse Wave VelocityBaseline, 1 hour post-chocolate, and hourly during 3 hours of prolonged sittingArterial stiffness will be assessed using estimated pulse wave velocity under each chocolate condition.
Heart Rate VariabilityBaseline, 1 hour post-chocolate, and hourly during 3 hours of prolonged sittingAutonomic cardiac function will be assessed using heart rate variability derived from RR interval recordings under each chocolate condition.
Heart RateBaseline, 1 hour post-chocolate, and hourly during 3 hours of prolonged sitting.Heart rate will be measured under each chocolate condition during the study visits.

Secondary

MeasureTime frameDescription
Capillary Blood GlucoseBaseline, 1 hour post-chocolate, and hourly during 3 hours of prolonged sittingCapillary blood glucose will be measured using finger-prick blood samples under each chocolate condition.
Appetite Visual Analog ScaleBaseline, 1 hour post-chocolate, and hourly during 3 hours of prolonged sittingSubjective appetite ratings will be assessed using a visual analog scale.
Pain Visual Analog ScaleBaseline, 1 hour post-chocolate, and hourly during 3 hours of prolonged sittingSubjective discomfort or pain during prolonged sitting will be assessed using a visual analog scale.
Calf CircumferenceBaseline and hourly during 3 hours of prolonged sittingCalf circumference will be measured to assess lower limb swelling during prolonged sitting.

Countries

Saudi Arabia

Contacts

CONTACTRazan S Alahmadi, MSc Candidate
rssarhan@ksu.edu.sa+966151988757
STUDY_DIRECTORAbdullah B Alansare, PhD

King Saud University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 30, 2026